No Data
No Data
No Data
No Data
No Data
來凱醫藥-B:2023年報
Futu NewsApr 26 05:01 ET · Announcements
Changes in Hong Kong stocks | Innovative drug concept stocks rose higher, Keji Pharmaceutical-B (02171) rose more than 11%, and innovative drugs ushered in a full-process support mechanism
Innovative drug concept stocks continued to rise. As of press release, Keji Pharmaceutical-B (02171) rose 10.3% to HK$5.57; Laikai Pharmaceutical-B (02105) rose 9.15% to HK$6.44; and Rongchang Biotech (09995) rose 6.29% to HK$31.25.
Zhitong FinanceApr 24 23:17 ET
Hong Kong stocks closed (04.23) | Hang Seng Index closed up 1.92%, TechNet stocks once again strong, Meituan-W (03690) rose nearly 8% to lead blue chips
UBS raised the Hong Kong stock rating to overrated, and the China Securities Regulatory Commission's five measures against Hong Kong boosted the market. Hong Kong stocks strengthened for two consecutive days.
Zhitong FinanceApr 23 04:41 ET
Changes in Hong Kong stocks | Pharmaceutical stocks strengthened in the afternoon, and the innovative drug policy showed a positive trend, and the sector is expected to continue to warm up after the second quarter
Pharmaceutical stocks strengthened in the afternoon. As of press release, Laikai Pharmaceutical-B (02105) rose 13.67% to HK$6.07; Conoa-B (02162) rose 13.21% to HK$33; and Pharmaceuticals (02268) rose 7.52% to HK$20.15.
Zhitong FinanceApr 23 01:55 ET
Changes in Hong Kong stocks | Laikai Pharmaceutical-B (02105) rose more than 8%. A new drug for obesity indications was recently approved in the US. The core pipeline has multiple catalysts this year
Laikai Pharmaceutical-B (02105) rose more than 8%. As of press release, it was up 7.3% to HK$5.73, with a turnover of HK$206.395 million.
Zhitong FinanceApr 22 23:24 ET
Statistics on changes in the share of Zhitong Hong Kong Stock Connect | April 18
Statistics on changes in the share of Zhitong Hong Kong Stock Connect | April 17, 2024
Zhitong FinanceApr 17 20:35 ET
No Data
No Data